(Q33719828)

28 July 2017

1 reference

title

Metabolism-based drug interactions involving oral azole antifungals in humans (English)

1 reference

28 July 2017

Strolin Benedetti M

1

1 reference

28 July 2017

Bani M

series ordinal

2

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

28 July 2017

published in

Drug Metabolism Reviews

1 reference

28 July 2017

volume

31

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

665-717

1 reference

Induction potential of fluconazole toward drug-metabolizing enzymes in rats

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Oral azole drugs as systemic antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Clinical pharmacokinetics of ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine*

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Interaction of fluconazole and cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Metabolism of 14C-busulfan in isolated perfused rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Cytochromes P450 mediating the N-demethylation of amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Effect of route of administration of fluconazole on the interaction between fluconazole and midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Fluconazole, but not terbinafine, enhances the effects of triazolam by inhibiting its metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Concentrations and effects of zopiclone are greatly reduced by rifampicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zopiclone

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Contribution of amine oxidases to the metabolism of xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Characterization of the cytochrome P450 isoenzymes involved in the in vitro N-dealkylation of haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Serum concentrations of clozapine and N-desmethylclozapine are unaffected by the potent CYP3A4 inhibitor itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: studies of phenytoin p-hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Contrasting effects of fluconazole and ketoconazole on phenytoin and testosterone disposition in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Fluconazole and phenytoin: a predictable interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Effects of ketoconazole on the polymorphic 4-hydroxylations of S-mephenytoin and debrisoquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Interaction between itraconazole and digoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Consumer requests for information regarding psychotropic drugs: experience from a national medicines phone-in.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of S-mephenytoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Disposition of ketoconazole, an oral antifungal, in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Potentiation of action of warfarin by itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Fluconazole in the treatment of candidal prosthetic valve endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Interaction between tolbutamide and ketoconazole in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Inducing properties of rifabutin, and effects on the pharmacokinetics and metabolism of concomitant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Urinary metabolites of rifabutin, a new antimycobacterial agent, in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Autoinduction of rifabutin metabolism in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Increased plasma rifabutin levels with concomitant fluconazole therapy in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Pharmacokinetics of didanosine and ketoconazole after coadministration to patients seropositive for the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Effect of fluconazole on pharmacokinetics of 2',3'-dideoxyinosine in persons seropositive for human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Macrolide antibacterials. Drug interactions of clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Influence of itraconazole on the pharmacokinetics and electrocardiographic effects of astemizole

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Lack of an effect of nefazodone on the pharmacokinetics and pharmacodynamics of theophylline during concurrent administration in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Theophylline has no advantages over caffeine as a putative model drug for assessing CYPIA2 activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Enzyme-inducing effects of bicalutamide in mouse, rat and dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Effects of ketoconazole on digoxin absorption and disposition in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

INTERACTION OF FLUCONAZOLE WITH CYCLOSPORIN

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

The Substrate Binding Site of Human Liver Cytochrome P450 2C9: An Approach Using Designed Tienilic Acid Derivatives and Molecular Modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Peripheral edema due to nifedipine-itraconazole interaction: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100101941

21 January 2018

Identifiers

DOI

10.1081/DMR-100101941

1 reference

28 July 2017

1 reference